SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000920465-15-000009
Filing Date
2015-03-16
Accepted
2015-03-16 16:24:09
Documents
10
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K ljpc-20141231x10k.htm 10-K 1200432
2 EXHIBIT 23.1 ljpc-20141231xexhibit231.htm EX-23.1 3129
3 EXHIBIT 31.1 ljpc-20141231xexhibit311.htm EX-31.1 14250
4 EXHIBIT 32.1 ljpc-20141231xexhibit321.htm EX-32.1 8068
  Complete submission text file 0000920465-15-000009.txt   5536406

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ljpc-20141231.xml EX-101.INS 571725
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ljpc-20141231.xsd EX-101.SCH 34338
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ljpc-20141231_cal.xml EX-101.CAL 38208
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ljpc-20141231_def.xml EX-101.DEF 196816
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ljpc-20141231_lab.xml EX-101.LAB 523599
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ljpc-20141231_pre.xml EX-101.PRE 293935
Mailing Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122
Business Address 4660 LA JOLLA VILLAGE DRIVE, SUITE 1070 SAN DIEGO CA 92122 858-207-4264
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36282 | Film No.: 15703215
SIC: 2836 Biological Products, (No Diagnostic Substances)